Shloka Negi

Shloka Negi

Auto-generated profile, based on publicly available information

Shloka Negi

UC Santa Cruz Genomics Institute, University of California

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 January 2025 in The American Journal of Human Genetics
Verified
Journal Article
Closed access
SNShloka Negi
Shloka Negi
SSSarah L. Stenton
Sarah L. Stenton
SBSeth I. Berger
Seth I. Berger
PCPaolo Canigiula
Paolo Canigiula
BMBrandy McNulty
Brandy McNulty
BPBenedict Paten
Benedict Paten

21 September 2025 in bioRxiv
Verified
Preprint
Open access
NHNancy F. Hansen
Nancy F. Hansen
NDNathan Dwarshuis
Nathan Dwarshuis
HJHyun Joo Ji
Hyun Joo Ji
ARArang Rhie
Arang Rhie
HLHailey Loucks
Hailey Loucks
APAdam M. Phillippy
Adam M. Phillippy
Human genome resequencing typically involves mapping reads to a reference genome to call variants; however, this approach suffers from both technical and reference biases, leaving many duplicated and structurally polymorphic regions of the genome unmapped. Consequently, existing variant benchmarks, generated by the same methods, fail to assess these complex regions. To address this limitation, we present a telomere-to-telomere genome benchmark that achieves near-perfect accuracy (i.e. no detectable errors) across 99.4% of the complete, diploid HG002 genome. This benchmark adds 701.4 Mb of autosomal sequence and both sex chromosomes (216.8 Mb), totaling 15.3% of the genome that was absent from prior benchmarks. We also provide a diploid annotation of genes, transposable elements, segmental duplications, and satellite repeats, including 39,144 protein-coding genes across both haplotypes. To facilitate application of the benchmark, we developed tools for measuring the accuracy of sequencing reads, phased variant call sets, and genome assemblies against a diploid reference. Genome-wide analyses show that state-of-the-art de novo assembly methods resolve 2–7% more sequence and outperform variant calling accuracy by an order of magnitude, yielding just one error per 100 kb across 99.9% of the benchmark regions. Adoption of genome-based benchmarking is expected to accelerate the development of cost-effective methods for complete genome sequencing, expanding the reach of genomic medicine to the entire genome and enabling a new era of personalized genomics.

11 February 2022 in Drug Delivery and Translational Research
Verified
Journal Article
Closed access
PDF file
SNShloka Negi
Shloka Negi
ACAISWARYA CHAUDHURI
AISWARYA CHAUDHURI
NDNaveen Kumar Dulla
Naveen Kumar Dulla
DDDeepa Dehari
Deepa Dehari
SSSanjay Singh
Sanjay Singh
AAAshish Kumar Agrawal
Ashish Kumar Agrawal

22 July 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
JLJulian K. Lucas
Julian K. Lucas
PHPrajna Hebbar
Prajna Hebbar
WLWen-Wei Liao
Wen-Wei Liao
JMJuan F. Macias-Velasco
Juan F. Macias-Velasco
ANAdam M. Novak
Adam M. Novak
BPBenedict Paten
Benedict Paten
A pangenome reference overcomes the inherent limitation of any individual reference genome by integrating the variation present in a population. We present the Human Pangenome Reference Consortium's (HPRC) Release 2 (HPRC2), an openly available, second phase pangenome that is an approximately fivefold expansion in genome number over HPRC Release 1 (HPRC1) and measurable improvement in genome completeness, contiguity, and accuracy. Selecting samples with a principled algorithm prioritising common variant coverage, HPRC2 contributes 460 haplotypes that together capture over 99% of common variation observed in the All of Us Research Program v8 cohort. Combining high-coverage long and ultra-long reads with modern assemblers and polishers, we produce thousands of telomere-to-telomere (T2T) chromosomes, and relative to HPRC1 halve the number of structurally unreliable regions as well as individual base errors per haplotype. We complement the assemblies with whole genome multiple alignments and gene annotations, and derive formal pangenome coordinate systems for addressing off-reference variation, demonstrating that individual human genomes contain more than one hundred thousand variants not succinctly described with respect to existing reference genomes. We also present the first matched long-read backed pantranscriptome and panepigenome at this scale, provide continuous local-ancestry estimates spanning every genome, and outline a host of new tools and applications that leverage the pangenome resource for improved genomics analysis.

12 January 2022 in Frontiers in Oncology
Verified
Journal Article
Open access
JTJayesh Kumar Tiwari
Jayesh Kumar Tiwari
SNShloka Negi
Shloka Negi
MKManju Kashyap
Manju Kashyap
SNSheikh Nizamuddin
Sheikh Nizamuddin
ASAmar Singh
Amar Singh
AKArun Khattri
Arun Khattri
Epithelial–mesenchymal transition (EMT) is a highly dynamic process that occurs under normal circumstances; however, EMT is also known to play a central role in tumor progression and metastasis. Furthermore, role of tumor immune microenvironment (TIME) in shaping anticancer immunity and inducing the EMT is also well recognized. Understanding the key features of EMT is critical for the development of effective therapeutic interventions. Given the central role of EMT in immune escape and cancer progression and treatment, we have carried out a pan-cancer TIME analysis of The Cancer Genome Atlas (TCGA) dataset in context to EMT. We have analyzed infiltration of various immune cells, expression of multiple checkpoint molecules and cytokines, and inflammatory and immune exhaustion gene signatures in 22 cancer types from TCGA dataset. A total of 16 cancer types showed a significantly increased (p < 0.001) infiltration of macrophages in EMT-high tumors (mesenchymal samples). Furthermore, out of the 17 checkpoint molecules we analyzed, 11 showed a significant overexpression (p < 0.001) in EMT-high samples of at least 10 cancer types. Analysis of cytokines showed significant enrichment of immunosuppressive cytokines—TGFB1 and IL10—in the EMT-high group of almost all cancer types. Analysis of various gene signatures showed enrichment of inflammation, exhausted CD8+ T cells, and activated stroma signatures in EMT-high tumors. In summary, our pan-cancer EMT analysis of TCGA dataset shows that the TIME of EMT-high tumors is highly immunosuppressive compared to the EMT-low (epithelial) tumors. The distinctive features of EMT-high tumors are as follows: (i) the enrichment of tumor-associated macrophages, (ii) overexpression of immune checkpoint molecules, (iii) upregulation of immune inhibitory cytokines TGFB1 and IL10, and (iv) enrichment of inflammatory and exhausted CD8+ T-cell signatures. Our study shows that TIMEs of different EMT groups differ significantly, and this would pave the way for future studies analyzing and targeting the TIME regulators for anticancer immunotherapy.

1 October 2025 in bioRxiv
Verified
Preprint
Open access
XCXian Chang
Xian Chang
ANAdam M. Novak
Adam M. Novak
JEJordan M. Eizenga
Jordan M. Eizenga
JSJouni Sirén
Jouni Sirén
JMJean Monlong
Jean Monlong
BPBenedict Paten
Benedict Paten
1 We previously introduced Giraffe, a short-read-to-pangenome graph mapper available in the vg pangenomics toolkit. Giraffe was fast and accurate for mapping short reads to human-scale pangenomes, but struggled with long reads. Long reads present a unique challenge to pangenome mapping algorithms due to their length and error profile, which allow them to take more topologically complex paths through the pangenome graph and increase the possible search space for the algorithm. We present updates to Giraffe that allow it to quickly and accurately map long reads to pangenome graphs. For both short and long reads, Giraffe mapping to a pangenome containing data from more than 450 human haplotypes, generated by the Human Pangenome Reference Consortium, is comparable in speed to linear mappers to human reference genomes; Giraffe is also over an order of magnitude faster than GraphAligner, the current state-of-the-art long-read-to-pangenome mapper. Its alignments produce similar or improved small and structural variant calling results, compared to those from commonly used graph-based and linear mappers. We additionally demonstrate using Giraffe’s long read alignments in a pangenome-guided assembly workflow, which is capable of producing more contiguous local assemblies than Hifiasm in our test regions.